Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis

NCT05726396 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT05726396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05726396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study Testing the Safety and Feasibility of Restorative Microbiota Therapy (RMT) in Patients With Refractory Immune-checkpoint Inhibitor-related Colitis
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Recruiting
Start date
September 23, 2025
Completion date
February 1, 2027
Enrollment
20 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

colitis, immune-related colitis